# Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)

> **NCT05128721** · PHASE1 · UNKNOWN · sponsor: **National Research Centre, Egypt** · enrollment: 72 (estimated)

## Conditions studied

- COVID-19
- Vaccine Reaction
- Vaccine Adverse Reaction

## Interventions

- **BIOLOGICAL:** Covi Vax

## Key facts

- **NCT ID:** NCT05128721
- **Lead sponsor:** National Research Centre, Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-14
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-05-23
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2021-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05128721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05128721, "Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05128721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*